Latest Insights - page 20 | BiopharmaTrend

UK Health-AI Push: NVIDIA Partnerships Back Sovereign Models from Imaging to Drug Design

NVIDIA is working with UK universities, research centers, and technology companies on applying AI across life sciences, robotics, healthcare, and generative model development. These collaborations form part of the UK’s …

Continue ›››

Stanford–Arc Team Reports AI-Made Viruses That Kill Bacteria

Researchers at Stanford University and the Arc Institute report they used a genome-scale generative model to design novel variants of bacteriophage phiX174; 16 of 302 AI-proposed genomes replicated in E. …

Continue ›››

BenchSci Reports New System to Extract Experimental Context From Biomedical Papers Into a Traceable Evidence Graph

BenchSci reports a method to convert biomedical papers into structured, evidence-linked data intended to support a Biological Evidence Knowledge Graph and neuro-symbolic reasoning across disease biology. The system is described …

Continue ›››

Lantern Pharma Reports AI-Guided LP-184 Meets Phase 1a Endpoints in Solid Tumors

Lantern Pharma, an oncology-focused company that applies artificial intelligence to drug development, has completed its Phase 1a trial of LP-184 in 63 patients with relapsed or refractory solid tumors, including …

Continue ›››

Biomni and Sage Partner on AI-Powered Access to Biomedical Data

Sage Bionetworks and Biomni have announced a collaboration that connects researchers to approximately 3 petabytes of curated biomedical datasets through natural language queries. The integration is designed to simplify discovery …

Continue ›››

Causaly Introduces Agentic Research AI Platform For Life Sciences R&D

Causaly has announced Causaly Agentic Research, a new AI platform designed to support life sciences R&D with domain-specific “agentic” AI. The system aims to outperform literature review tools and general-purpose …

Continue ›››

datma Launches Federated Biomarker Explorer for Health Systems

datma has introduced Federated Biomarker Explorer for Health Systems, a tool designed for hospitals, cancer centers, and laboratories to gauge pharmaceutical demand for their healthcare data without sharing patient records …

Continue ›››

Medra Launches AI-Driven Platform for Continuous Scientific Experimentation

Medra, a San Francisco–based startup, has unveiled its Continuous Science Platform, a system designed to accelerate experimental research by integrating robotics with proprietary AI models. The platform is presented as …

Continue ›››

Lila Sciences Raises $235M to Build Autonomous AI Labs, Joins Unicorn Ranks

Lila Sciences has raised $235 million in Series A financing, a round that values the Cambridge-based startup at more than $1 billion less than a year after its launch. The …

Continue ›››

Google’s AI Auto-Writes Reproducible Research Software for Genomics and COVID Forecasting

Google Research introduced a Gemini-based system that writes and iteratively improves “empirical software,” with a preprint and an interactive site showing full solution trees. The system treats well-defined scientific problems …

Continue ›››

Phesi Reports GLP-1 Trials Now Span 100+ Diseases

Phesi has published an analysis showing that GLP-1 drugs are now being tested across more than 100 diseases, extending well beyond their established use in diabetes and obesity. The findings …

Continue ›››

Tempus AI Validates RNA-Based Algorithm for Pancreatic Cancer Therapy Selection

Tempus has reported results validating its PurIST algorithm as a biomarker to guide chemotherapy choice in advanced pancreatic ductal adenocarcinoma (PDAC). The study reportedly represents the largest real-world analysis of …

Continue ›››